PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis
ObjectivePulmonary hypertension (PH) in context with interstitial lung disease (ILD) portends serious clinical consequences and a high rate of mortality. Recently published randomized controlled trials (RCTs) which assessed the pulmonary arterial hypertension (PAH)-specific drugs for pulmonary hyper...
| Κύριοι συγγραφείς: | , , , , , , , , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Frontiers Media S.A.
2022-11-01
|
| Σειρά: | Frontiers in Cardiovascular Medicine |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.992879/full |